Overview

Title

To prohibit data brokers from selling and transferring certain sensitive data.

ELI5 AI

The bill wants to stop people who collect and sell personal information from selling or sharing things like where people are or health details, and it will ask a special group to check and make sure everyone follows the rules.

Summary AI

The bill S. 5462, titled the “Health and Location Data Protection Act of 2024,” aims to make it illegal for data brokers to sell or share sensitive personal data like health and location information. The Federal Trade Commission (FTC) would enforce these rules and be responsible for creating regulations to define this type of data. The bill allows states and private individuals to take legal action if a data broker violates these rules and sets civil penalties for violations. It also indicates exceptions for HIPAA-compliant actions and the publication of newsworthy information.

Published

2024-12-10
Congress: 118
Session: 2
Chamber: SENATE
Status: Introduced in Senate
Date: 2024-12-10
Package ID: BILLS-118s5462is

Bill Statistics

Size

Sections:
5
Words:
2,498
Pages:
13
Sentences:
55

Language

Nouns: 765
Verbs: 189
Adjectives: 149
Adverbs: 20
Numbers: 89
Entities: 160

Complexity

Average Token Length:
4.24
Average Sentence Length:
45.42
Token Entropy:
5.22
Readability (ARI):
24.77

AnalysisAI

General Summary of the Bill

The bill, titled the Health and Location Data Protection Act of 2024, seeks to regulate how data brokers handle certain types of sensitive data. Specifically, it prohibits data brokers from selling, sharing, or otherwise transferring health data, location data, and other related information. Exceptions to this rule are made for actions compliant with health privacy laws like HIPAA, the publication of newsworthy information, and cases where individuals have provided valid authorization for their data to be shared. The Federal Trade Commission (FTC) will be responsible for enforcing these regulations.

Summary of Significant Issues

A number of significant issues arise from the draft of this bill:

  1. Ambiguity in Definitions: Key terms such as "data broker," "sell," "resell," "license," "trade," "transfer," "share," and "other forms of data" are not clearly defined in the text, which could lead to interpretative challenges and hinder effective enforcement.

  2. Broad Enforcement Powers: The bill grants expansive enforcement powers to the FTC, especially concerning nonprofit organizations, without specifying limitations, which could lead to inconsistent application of the law.

  3. Revenue-Based Penalties: There are provisions for civil penalties based on a percentage of a company's revenue that might unduly impact businesses with multiple lines of operation that are unrelated to any violation of the Act.

  4. Broad Definitions of Data: The definitions for "health data" and "data" in general are comprehensive yet potentially too broad, possibly capturing more information than intended and raising privacy concerns.

  5. Interaction with State Laws: The legislation does not clearly address potential overlaps with or conflicts between federal and state laws, which might lead to legal confusion.

Impact on the Public

The broad public impact of this bill centers on privacy protection. By restricting how sensitive health and location data can be sold and shared, it aims to enhance personal data privacy and security. Consumers would have greater confidence that their personal information isn't being transferred without their consent, particularly sensitive data like health conditions or their physical location.

However, the lack of clear definitions and guidance might lead to varied interpretations of the law, potentially resulting in uneven enforcement and compliance. Consumers could see delays in the benefits of these protections due to complex implementation.

Impact on Specific Stakeholders

Certain groups will be particularly affected by this legislation:

  1. Data Brokers: Companies dealing in data brokerage will face new compliance challenges. They will need to adapt quickly to new regulations, potentially involving significant adjustments to their operations and data handling processes. The broad reach of the definitions could encompass a wider array of businesses than initially intended.

  2. Businesses with Diversified Operations: The potential for penalties based on a percentage of the parent company's revenues may unfairly penalize diversified companies, imposing financial burdens not aligned with the scale or nature of the violation in question.

  3. Federal Trade Commission (FTC): The FTC will see expanded responsibilities, necessitated by the oversight and enforcement of the Act. The significant funding increase allocated by the bill is intended to support these new duties, although the long time frame for use of these funds might raise concerns about resource allocation efficiency.

Overall, while the bill aims for greater protection of individual privacy, its impact will significantly depend on the clarity of implementation and interpretation of its provisions, as well as the ability of companies and regulatory bodies to navigate the ambiguities within its text.

Financial Assessment

The bill titled “Health and Location Data Protection Act of 2024” introduces significant financial considerations through the allocation of funds to support its enforcement. Below is a detailed commentary on how the financial aspects are outlined in the bill, their implications, and how they relate to the issues identified.

Appropriation of Funds

The bill sets aside $1,000,000,000 to be appropriated to the Federal Trade Commission (FTC) for fiscal year 2025. These funds are intended to "carry out the work of the Commission" related to the enforcement of the Act and will remain available until September 30, 2034. This large financial allocation underscores the importance placed on enforcing the restrictions on data brokers and signifies a robust commitment to safeguarding sensitive health and location data.

Relation to Identified Issues

Potential Wasteful Spending:

One of the issues flagged in the identified concerns is the potential for wasteful spending given the substantial allocation of funds without a detailed explanation of how these resources will be utilized. Allocating $1 billion is considerable, and its intended use is not broken down into specific components within the bill. Without a detailed budget or spending plan, there's a risk that this appropriation could lead to inefficient or ineffective use of taxpayer money, which often raises red flags regarding fiscal responsibility.

Enforcement and Compliance Adaptation Costs:

The allocation of funds is crucial given the rigorous enforcement and regulatory tasks that the FTC is expected to undertake. However, if the FTC is unable to issue final rules within the stipulated 180 days, businesses may face rushed compliance requirements. This could inadvertently lead to increased costs for businesses as they attempt to adapt to regulations without comprehensive guidance—a situation compounded by the lack of clarity on the definition of "data."

Broader Financial Implications

The financial allocation in this bill is indicative of the importance attributed to consumer data protection and privacy. However, the sheer size of the allocation calls for careful oversight to ensure that the funds achieve the intended outcomes without unnecessary expenditure. In light of concerns about the breadth and potential for overreach within the bill's provisions, diligent financial management will be essential to balance enforcement with fairness and practicality for affected businesses.

In conclusion, while the bill makes a strong financial commitment to its objectives, stakeholders will need transparency and accountability measures to ensure the funds are effectively and efficiently used, thereby avoiding wasteful spending and aligning with the overarching goals of data protection and privacy.

Issues

  • The terms 'data broker', 'sell, resell, license, trade, transfer, share', and 'other forms of data' in Section 2 are not defined, creating potential ambiguity and challenges in enforcement and compliance.

  • The enforcement powers granted to the Federal Trade Commission (FTC) regarding nonprofit organizations in Section 3 are not limited or specified, potentially leading to broad or inconsistent application.

  • The provision in Section 3 regarding civil penalties based on 15 percent of the revenues of the ultimate parent entity could disproportionately impact companies with diversified business lines unrelated to the violation.

  • The definition of 'data' in Section 4 is left to be determined by the Commission via future rulemaking, leading to ambiguity and lack of clarity until those rules are established.

  • The definition of 'health data' in Section 4 is comprehensive but may be excessively broad, potentially encompassing more information than intended and raising privacy concerns.

  • The effective date in Section 2 could impose rushed compliance requirements if the Commission fails to issue final rules within 180 days, affecting businesses' ability to adapt in time.

  • Interaction between this federal act and existing state laws is not adequately addressed, particularly concerning overlap or conflicts outside of disclosure requirements, as mentioned in Section 3, leading to potential legal challenges or confusion.

  • The allocation of $1,000,000,000 in Section 5 is a significant expenditure without detailed justification or breakdown of costs, raising concerns about potential wasteful spending.

  • The Act's reliance on external regulations for defining 'ultimate parent entity' in Section 4 could lead to issues if these regulations change, affecting the Act's application without further legislative review.

Sections

Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.

1. Short title Read Opens in new tab

Summary AI

The Health and Location Data Protection Act of 2024 is the official name given to this legislative act.

2. Unfair and deceptive acts and practices relating to health and location data Read Opens in new tab

Summary AI

The bill makes it illegal for data brokers to sell or share people's health or location data, unless it's allowed by health privacy laws (like HIPAA), is newsworthy, or the person has given permission. The rules will take effect either when the relevant commission issues its final regulations or 180 days after the bill is passed, and the commission can provide more guidance if needed.

3. Enforcement Read Opens in new tab

Summary AI

The section outlines how the Federal Trade Commission (FTC), states, and individuals can enforce the rules against data brokers that violate the act. It explains the roles of the FTC and state attorneys general in bringing civil actions, specifies penalties for violations, determines where legal actions can be filed, and sets a 6-year time limit to start legal proceedings.

4. Definitions Read Opens in new tab

Summary AI

The section defines key terms used in the Act, detailing the roles and meanings of the Commission, data, data broker, health data, location data, State, and ultimate parent entity. It specifies that "data" refers to information linked to individuals or groups, "health data" covers various health-related information, and outlines what constitutes "location data."

5. Funding Read Opens in new tab

Summary AI

For the fiscal year 2025, the Commission is allocated $1 billion from the Treasury, which will be available until September 30, 2034, to support its operations.

Money References

  • In addition to amounts otherwise available, there is appropriated to the Commission for fiscal year 2025, out of any money in the Treasury not otherwise appropriated, $1,000,000,000, to remain available until September 30, 2034, for carrying out the work of the Commission.